|
1
|
Hausenloy DJ, Boston-Griffiths E and
Yellon DM: Cardioprotection during cardiac surgery. Cardiovasc Res.
94:253–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scherz-Shouval R and Elazar Z: ROS,
mitochondria and the regulation of autophagy. Trends Cell Biol.
17:422–427. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Glinka YY and Youdim MB: Inhibition of
mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J
Pharmacol. 292:329–332. 1995.PubMed/NCBI
|
|
5
|
Wasserman WW and Fahl WE: Functional
antioxidant responsive elements. Proc Natl Acad Sci USA.
94:5361–5366. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan K, Han XD and Kan YW: An important
function of Nrf2 in combating oxidative stress: detoxification of
acetaminophen. Proc Natl Acad Sci USA. 98:4611–4616. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Itoh K, Wakabayashi N, Katoh Y, Ishii T,
Igarashi K, Engel JD and Yamamoto M: Keap1 represses nuclear
activation of antioxidant responsive elements by Nrf2 through
binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mann GE, Bonacasa B, Ishii T and Siow RC:
Targeting the redox sensitive Nrf2-Keap1 defense pathway in
cardiovascular disease: protection afforded by dietary isoflavones.
Curr Opin Pharmacol. 9:139–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boon RA and Dimmeler S: MicroRNAs in
myocardial infarction. Nat Rev Cardiol. 12:135–142. 2015.
View Article : Google Scholar
|
|
13
|
Guo Y, Yu S, Zhang C and Kong AN:
Epigenetic regulation of Keap1-Nrf2 signaling. Free Radic Biol Med.
88:337–349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cufí S, Vazquez-Martin A,
Oliveras-Ferraros C, Quirantes R, Segura-Carretero A, Micol V,
Joven J, Bosch-Barrera J, Del Barco S, Martin-Castillo B, et al:
Metformin lowers the threshold for stress-induced senescence: a
role for the microRNA-200 family and miR-205. Cell Cycle.
11:1235–1246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: miR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Al Ghouleh I, Khoo NK, Knaus UG,
Griendling KK, Touyz RM, Thannickal VJ, Barchowsky A, Nauseef WM,
Kelley EE, Bauer PM, et al: Oxidases and peroxidases in
cardiovascular and lung disease: new concepts in reactive oxygen
species signaling. Free Radic Biol Med. 51:1271–1288. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Becker LB: New concepts in reactive oxygen
species and cardiovascular reperfusion physiology. Cardiovasc Res.
61:461–470. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaspar JW, Niture SK and Jaiswal AK:
Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol
Med. 47:1304–1309. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niture SK, Khatri R and Jaiswal AK:
Regulation of Nrf2 - an update. Free Radic Biol Med. 66:36–44.
2014. View Article : Google Scholar
|
|
20
|
Lee LY, Harberg C, Matkowskyj KA, Cook S,
Roenneburg D, Werner S, Johnson J and Foley DP: Overactivation of
the nuclear factor (erythroid-derived 2)-like 2-antioxidant
response element pathway in hepatocytes decreases hepatic
ischemia/reperfusion injury in mice. Liver Transpl. 22:91–102.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mohammadzadeh M, Halabian R, Gharehbaghian
A, Amirizadeh N, Jahanian-Najafabadi A, Roushandeh AM and Roudkenar
MH: Nrf-2 overexpression in mesenchymal stem cells reduces
oxidative stress-induced apoptosis and cytotoxicity. Cell Stress
Chaperones. 17:553–565. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saito Y, Tsuruma K, Ichihara K, Shimazawa
M and Hara H: Brazilian green propolis water extract up-regulates
the early expression level of HO-1 and accelerates Nrf2 after UVA
irradiation. BMC Complement Altern Med. 15:4212015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv H, Ren H, Wang L, Chen W, Ci X and Lico
A: Lico A enhances Nrf2-mediated defense mechanisms against
t-BHP-induced oxidative stress and cell death via Akt and ERK
activation in RAW 264.7 cells. Oxid Med Cell Longev.
2015:7098452015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang K, Jiang Y, Wang W, Ma J and Chen M:
Escin activates AKT-Nrf2 signaling to protect retinal pigment
epithelium cells from oxidative stress. Biochem Biophys Res Commun.
468:541–547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang G, Liu X, Wang M, Chen H, Chen Z and
Qiu T: Oxymatrine ameliorates renal ischemia-reperfusion injury
from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras.
30:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muthusamy VR, Kannan S, Sadhaasivam K,
Gounder SS, Davidson CJ, Boeheme C, Hoidal JR, Wang L and
Rajasekaran NS: Acute exercise stress activates Nrf2/ARE signaling
and promotes antioxidant mechanisms in the myocardium. Free Radic
Biol Med. 52:366–376. 2012. View Article : Google Scholar
|
|
27
|
Tsai CY, Wang CC, Lai TY, Tsu HN, Wang CH,
Liang HY and Kuo WW: Antioxidant effects of diallyl trisulfide on
high glucose-induced apoptosis are mediated by the
PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes. Int J
Cardiol. 168:1286–1297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Sano M, Shinmura K, Tamaki K,
Katsumata Y, Matsuhashi T, Morizane S, Ito H, Hishiki T, Endo J, et
al: 4-hydroxy-2-nonenal protects against cardiac
ischemia-reperfusion injury via the Nrf2-dependent pathway. J Mol
Cell Cardiol. 49:576–586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng C, Sun Z, Tong G, Yi W, Ma L, Zhao B,
Cheng L, Zhang J, Cao F and Yi D: α-Lipoic acid reduces infarct
size and preserves cardiac function in rat myocardial
ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2
pathway. PLoS One. 8:e583712013. View Article : Google Scholar
|
|
30
|
Katsumata Y, Shinmura K, Sugiura Y,
Tohyama S, Matsuhashi T, Ito H, Yan X, Ito K, Yuasa S, Ieda M, et
al: Endogenous prostaglandin D2 and its metabolites protect the
heart against ischemia-reperfusion injury by activating Nrf2.
Hypertension. 63:80–87. 2014. View Article : Google Scholar
|
|
31
|
Chen XQ, Wu SH, Zhou Y and Tang YR:
Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against
hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE
complex. PLoS One. 8:e671202013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wells G: Peptide and small molecule
inhibitors of the Keap1-Nrf2 protein-protein interaction. Biochem
Soc Trans. 43:674–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abed DA, Goldstein M, Albanyan H, Jin H
and Hu L: Discovery of direct inhibitors of Keap1-Nrf2
protein-protein interaction as potential therapeutic and preventive
agents. Acta Pharm Sin B. 5:285–299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei J, Zhang Y, Luo Y, Wang Z, Bi S, Song
D, Dai Y, Wang T, Qiu L, Wen L, et al: Aldose reductase regulates
miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2
signaling in renal mesangial cells and the renal cortex of diabetic
mice. Free Radic Biol Med. 67:91–102. 2014. View Article : Google Scholar
|
|
35
|
Shi L, Wu L, Chen Z, Yang J, Chen X, Yu F,
Zheng F and Lin X: MiR-141 activates Nrf2-dependent antioxidant
pathway via down-regulating the expression of Keap1 conferring the
resistance of hepatocellular carcinoma cells to 5-fluorouracil.
Cell Physiol Biochem. 35:2333–2348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou L, Xu DY, Sha WG, Shen L, Lu GY, Yin
X and Wang MJ: High glucose induces renal tubular epithelial injury
via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. J Transl Med.
13:3522015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eades G, Yang M, Yao Y, Zhang Y and Zhou
Q: miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in
breast cancer cells. J Biol Chem. 286:40725–40733. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang JJ, Tao H, Hu W, Liu LP, Shi KH, Deng
ZY and Li J: MicroRNA-200a controls Nrf2 activation by target Keap1
in hepatic stellate cell proliferation and fibrosis. Cell Signal.
26:2381–2389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sangokoya C, Telen MJ and Chi JT: microRNA
miR-144 modulates oxidative stress tolerance and associates with
anemia severity in sickle cell disease. Blood. 116:4338–4348. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang M, Yao Y, Eades G, Zhang Y and Zhou
Q: MiR-28 regulates Nrf2 expression through a Keap1-independent
mechanism. Breast Cancer Res Treat. 129:983–991. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Singh B, Ronghe AM, Chatterjee A, Bhat NK
and Bhat HK: MicroRNA-93 regulates NRF2 expression and is
associated with breast carcinogenesis. Carcinogenesis.
34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma Q and Zhang L: Epigenetic programming
of hypoxic-ischemic encephalopathy in response to fetal hypoxia.
Prog Neurobiol. 124:28–48. 2015. View Article : Google Scholar
|
|
43
|
Wiklund ED, Bramsen JB, Hulf T, Dyrskjøt
L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS,
Borre M, et al: Coordinated epigenetic repression of the miR-200
family and miR-205 in invasive bladder cancer. Int J Cancer.
128:1327–1334. 2011. View Article : Google Scholar
|
|
44
|
Santra M, Chopp M, Santra S, Nallani A,
Vyas S, Zhang ZG and Morris DC: Thymosin beta 4 up-regulates
miR-200a expression and induces differentiation and survival of rat
brain progenitor cells. J Neurochem. 136:118–132. 2016. View Article : Google Scholar
|
|
45
|
Li R, He JL, Chen XM, Long CL, Yang DH,
Ding YB, Qi HB and Liu XQ: MiR-200a is involved in proliferation
and apoptosis in the human endometrial adenocarcinoma cell line
HEC-1B by targeting the tumor suppressor PTEN. Mol Biol Rep.
41:1977–1984. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ahmed RP, Haider HK, Buccini S, Li L,
Jiang S and Ashraf M: Reprogramming of skeletal myoblasts for
induction of pluripotency for tumor-free cardiomyogenesis in the
infarcted heart. Circ Res. 109:60–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
